Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study. - Wikidata - awgldk - TriplyDB

Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.

Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.

http://www.wikidata.org/entity/Q37138794

about

Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis Approved Antiviral Drugs over the Past 50 Years Adverse effects of oral antiviral therapy in chronic hepatitis B.Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model.Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment.Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification.

P2860

Q26766014-0793B7D6-65C7-45BE-B159-034ADECFB41B Q27755387-1A73859E-890A-4E0E-8D54-41CEE64155AC Q37651892-7EDD5085-A0C6-4FAC-B610-6E230DD874FA Q38559455-4936100D-A1DC-4390-B436-082BA444F184 Q41328399-06D1EA13-E75D-497D-8190-C87217C3334D Q47596434-4EC91F92-53B1-45EE-A45C-519B945423F8 Q55034780-D568509C-DB97-4E75-A7D4-216DAABBBA59

P2860

Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.

http://www.wikidata.org/entity/Q37138794

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@en

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@nl

type

label

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@en

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@nl

prefLabel

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@en

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@nl

P1433

Q37138794-91FFDBA2-A113-4C82-B5E8-366D83583D74

P1476

Q37138794-5408611C-752E-4280-A122-47E248CA8BEA

P2093

Q37138794-1D347F1C-4923-49A7-A744-FE8859A70FD4

Q37138794-5B340D3E-7F56-4E5E-92AE-B470C762B327

Q37138794-A69984A3-E589-42A4-AAC6-43312EC16D4A

Q37138794-D15634BF-FBC1-4584-9E56-6360BA34B288

P2860

Q37138794-01FF6490-3DD8-4290-9177-F3B931753FD4

Q37138794-02FE45D5-CB6E-4532-A10F-13AA2C9DA718

Q37138794-09FD61DB-7ACB-4F1B-94DF-EF7C6091C41E

Q37138794-14A2476F-89EF-43F0-898A-50BD05DA5928

Q37138794-167CE660-8D21-4F2A-8021-AD3D6BE5CA66

Q37138794-23981F04-546C-4B97-8985-CC1109300FB2

Q37138794-3187201B-AAE8-469D-AF10-2D62326F7B51

Q37138794-463882DC-58C9-43DB-9032-462418CE3B3F

Q37138794-4A139FCC-F596-40B0-BCDB-2F2661566833

Q37138794-4C145C58-EB01-4A79-9BCD-EA35B3E73A2E

P304

Q37138794-3BF90C2F-EF17-46E0-A942-DF6333A636B6

P31

Q37138794-5E96F88E-A85F-4927-A72F-1D2DFFE0C0CD

P356

Q37138794-3298351C-191D-4A1B-BE74-700C805452D1

P407

Q37138794-AE887AF9-509F-439D-A51D-BB52F21D3AEA

P433

Q37138794-D9AC82B2-8D2F-41F8-BA65-FFD691CB09B7

P478

Q37138794-A65CC4BE-EE5C-425F-891D-55FB50857E78

P577

Q37138794-9735D29B-E001-43EE-93BC-D702FBBCACD6

P5875

Q37138794-BA447C53-9D14-41D6-9F6D-7781747271DA

P698

Q37138794-7A67DE84-82CE-4A67-AA56-9A4DDB1676D7

P932

Q37138794-097A7AB4-0C57-44E8-8610-1608D1A215A1

P356

P1433

Hepatitis Monthly

P1476

Efficacy and Safety of Telbivu ...... tients: a Meta-Analysis Study.

@en

P2093

Jian Liang

http://www.w3.org/2001/XMLSchema#string

Man Jun Jiang

http://www.w3.org/2001/XMLSchema#string

Xiao Xiao Zhou

http://www.w3.org/2001/XMLSchema#string

Xin Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

Bias in meta-analysis detected by a simple, graphical test

Operating characteristics of a rank correlation test for publication bias

Meta-analysis in clinical trials

Statistical aspects of the analysis of data from retrospective studies of disease

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial

Publication bias in clinical research

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B

P304

e7862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/HEPATMON.7862

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256542392

http://www.w3.org/2001/XMLSchema#string

P698

24032045

http://www.w3.org/2001/XMLSchema#string

P932

3759781

http://www.w3.org/2001/XMLSchema#string